PEOPLE - Changes at Young Innovations:
This article was originally published in Clinica
Executive Summary
Dental equipment supplier Young Innovations has made several management changes. President and CEO Alfred Brennan has been named vice chairman of the board of directors and CEO. His successor in the post of president is Arthur Herbst, previously CFO and COO. Vice-president of finance Christine Boehning has been promoted to CFO, having joined the St Louis, Missouri-based company only in February and been already promoted in May. Daniel Tarullo has been appointed vice-president of business development.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.